129 related articles for article (PubMed ID: 38342005)
1. High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining.
Höhn AK; Forberger M; Alfaraidi M; Gilks CB; Brambs CE; Höckel M; Hoang L; Singh N; Horn LC
Gynecol Oncol; 2024 Jun; 185():17-24. PubMed ID: 38342005
[TBL] [Abstract][Full Text] [Related]
2. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
Yang H; Almadani N; Thompson EF; Tessier-Cloutier B; Chen J; Ho J; Senz J; McConechy MK; Chow C; Ta M; Cheng A; Karnezis A; Huvila J; McAlpine JN; Gilks B; Jamieson A; Hoang LN
Mod Pathol; 2023 Jun; 36(6):100145. PubMed ID: 36828360
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.
Pouwer AW; Te Grootenhuis NC; Hinten F; de Bock GH; van der Zee AGJ; Melchers WJG; Oonk MHM; de Hullu JA; Hollema H; Bulten J
Virchows Arch; 2024 Jun; 484(6):985-994. PubMed ID: 37938322
[TBL] [Abstract][Full Text] [Related]
4. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
5. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma.
Proctor L; Hoang L; Moore J; Thompson E; Leung S; Natesan D; Chino J; Gilks B; McAlpine JN
Int J Gynecol Cancer; 2020 Jan; 30(1):100-106. PubMed ID: 31771962
[TBL] [Abstract][Full Text] [Related]
6. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
7. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
[TBL] [Abstract][Full Text] [Related]
8. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.
Santos M; Montagut C; Mellado B; García A; Ramón y Cajal S; Cardesa A; Puig-Tintoré LM; Ordi J
Int J Gynecol Pathol; 2004 Jul; 23(3):206-14. PubMed ID: 15213596
[TBL] [Abstract][Full Text] [Related]
10. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.
Thompson EF; Hoang L; Höhn AK; Palicelli A; Talia KL; Tchrakian N; Senz J; Rusike R; Jordan S; Jamieson A; Huvila J; McAlpine JN; Gilks CB; Höckel M; Singh N; Horn LC
Int J Gynecol Cancer; 2022 Aug; 32(8):977-985. PubMed ID: 35764349
[TBL] [Abstract][Full Text] [Related]
11. p53 Immunohistochemical Patterns in HPV-Independent Squamous Cell Carcinomas of the Vulva and the Associated Skin Lesions: A Study of 779 Cases.
Rakislova N; Alemany L; Clavero O; Saco A; Torné A; Del Pino M; Munmany M; Rodrigo-Calvo MT; Guerrero J; Marimon L; Vega N; Quirós B; Lloveras B; Ribera-Cortada I; Alejo M; Pawlita M; Quint W; de Sanjose S; Ordi J; Vvap Study Group
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138328
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.
Rosenthal AN; Hopster D; Ryan A; Jacobs IJ
Br J Cancer; 2003 Jan; 88(2):251-6. PubMed ID: 12610510
[TBL] [Abstract][Full Text] [Related]
13. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.
Davidson B; Skeie-Jensen T; Holth A; Lindemann K; Toralba Barrameda AM; Lie AK; Wang Y
Virchows Arch; 2024 Jun; 484(6):951-963. PubMed ID: 37843640
[TBL] [Abstract][Full Text] [Related]
15. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
Xing D; Fadare O
Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
[TBL] [Abstract][Full Text] [Related]
16. Differentiated Vulvar Intraepithelial Neoplasia-like and Lichen Sclerosus-like Lesions in HPV-associated Squamous Cell Carcinomas of the Vulva.
Rakislova N; Alemany L; Clavero O; Del Pino M; Saco A; Quirós B; Lloveras B; Alejo M; Halec G; Quint W; de Sanjosé S; Ordi J;
Am J Surg Pathol; 2018 Jun; 42(6):828-835. PubMed ID: 29505429
[TBL] [Abstract][Full Text] [Related]
17. "Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".
Rakislova N; Clavero O; Alemany L; Saco A; Quirós B; Lloveras B; Alejo M; Pawlita M; Quint W; Del Pino M; de Sanjose S; Ordi J;
Int J Cancer; 2017 Dec; 141(12):2517-2527. PubMed ID: 28815579
[TBL] [Abstract][Full Text] [Related]
18. Expanding the Morphologic, Immunohistochemical, and HPV Genotypic Features of High-grade Squamous Intraepithelial Lesions of the Vulva With Morphology Mimicking Differentiated Vulvar Intraepithelial Neoplasia and/or Lichen Sclerosus.
Griesinger LM; Walline H; Wang GY; Lorenzatti Hiles G; Welch KC; Haefner HK; Lieberman RW; Skala SL
Int J Gynecol Pathol; 2021 May; 40(3):205-213. PubMed ID: 32925443
[TBL] [Abstract][Full Text] [Related]
19. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.
Carreras-Dieguez N; Saco A; Del Pino M; Marimon L; López Del Campo R; Manzotti C; Fusté P; Pumarola C; Torné A; Garcia A; Rakislova N
Histopathology; 2023 Jul; 83(1):17-30. PubMed ID: 37099408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
